HIV Alert: Managing HIV/HCV Coinfection

In this downloadable slideset, Annie Luetkemeyer, MD, and Mark Sulkowski, MD, provide expert insight on managing HIV in the setting of HCV coinfection.
Format: Microsoft PowerPoint (.ppt)
File Size: 401 KB
Released: December 5, 2017

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

What do the latest clinical data show about giving rifampin with dolutegravir, bictegravir, or tenofovir alafenamide?

Daniel R. Kuritzkes, MD Released: April 27, 2018

In this downloadable slideset, Frederick L. Altice, MD, reviews the HIV treater’s role at the intersection of HIV infection, HCV infection, and the opioid crisis.

Released: April 26, 2018

Listen to downloadable audio from a series of live Webinars by Paul E. Sax, MD, and Brian Wood, MD, in which the use of recently approved integrase inhibitor–based regimens is discussed and audience questions on this subject are addressed.

Released: April 23, 2018

In this downloadable slideset, Daniel R. Kuritzkes, MD, and Program Directors Joseph J. Eron, Jr., MD, and Princy N. Kumar, MD, review key HIV data presented at the CROI 2018 meeting.

Released: April 20, 2018

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?